Dr. Pirouz Daftarian completed his PhD training in immunology in Faculty of Medicine of the University of Ottawa, in 1998. Since then, he has been leading studies on cancer immunology and autoimmunity, in academia, and biotech. He joined Crown Bioscience / JSR Life Sciences in 2017 and led the developing applications for IO products and as a Director of Scientific Engagement for models of autoimmunity and In Vitro IO. Of prior experience, Pirouz was with NGM Biopharmaceutical, was a faculty at Miller School of Medicine of University of Miami and a Head Scientist, Cancer Biology, at IMV Inc. Pirouz has authored > 80 peer reviewed papers, has served as a reviewer of DOD, NIH, NCI, is a reviewer for several journals, and acted as a consultant pharma and biotech companies.